| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.25 | 0.07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |